SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$52.92
+0.28 (+0.53%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+10.60%
1Y
+68.56%
YTD
+23.64%
Open$53.30
Previous Close$52.64
Day High$53.68
Day Low$50.77
52W High$58.49
52W Low$27.07
Volume—
Avg Volume1.14M
Market Cap5.70B
P/E Ratio—
EPS$-3.45
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.16
Above
SMA 200
$36.91
Above
RSI (14)
59.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+34.7% upside
Current
$52.92
$52.92
Target
$71.29
$71.29
$54.07
$71.29 avg
$91.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 910.50M | 880.80M | 846.68M |
| Net Income | -11,497,538 | -12,296,426 | -11,692,649 |
| Profit Margin | -1.3% | -1.4% | -1.4% |
| EBITDA | -11,509,292 | -12,212,052 | -11,111,961 |
| Free Cash Flow | -10,999,659 | -14,100,591 | -9,156,076 |
| Rev Growth | +11.0% | +3.4% | +15.4% |
| Debt/Equity | 0.75 | 0.83 | 0.78 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $245.22 | +0.55% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $407.95 | +0.77% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $133.75 | +2.21% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $782.10 | +1.29% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.68 | +0.72% | 47.7 | 27.52B |